Back to search

Article

Nanoparticle-mediated Targeting of the Fusion Gene <i>RUNX1/ETO</i> in t(8;21)-positive Acute Myeloid Leukaemia

2022-09-21

Abstract excerpt

A hallmark of acute myeloid leukaemias (AMLs) are chromosomal rearrangements that give rise to novel leukaemia-specific fusion genes. Most of these fusion genes are both initiating and driving events in AML and therefore constitute ideal therapeutic targets but are challenging to target by conventional drug development. siRNAs are frequently used for the specific suppression of fusion gene expression but require s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bae82196-b54f-5ee0-b23b-a4723dd51c12
DOI
10.1101/2022.09.21.508893
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nanoparticle-mediated Targeting of the Fusion Gene <i>RUNX1/ETO</i> in t(8;21)-positive Acute Myeloid LeukaemiaDOI 10.1101/2022.09.21.508893
Select a neighboring publication to make it the new centre.